Developmental toxicity studies of the quinolone antibacterial agent irloxacin in rats and rabbits

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 2, 2003, Pages 121-125

  Guzmán, Antonio ^a   García, Concepción ^a   Marín, Ana Paz ^a   Willoughby, Chris ^b   Demestre, Isabel ^a  

^a Laboratorios Dr Esteve SA   (Spain)

^b HUNTINGDON LIFE SCIENCES   (United Kingdom)

Author keywords

Antibacterials; CAS 91524 15 1; Irloxacin, embryotoxicity, rabbit, rat, teratogenicity; Quinolones

Indexed keywords

IRLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABORTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; EMBRYOTOXICITY; FECES LEVEL; FEMALE; FETUS DEVELOPMENT; FETUS MALFORMATION; FETUS WEIGHT; FOOD INTAKE; INTRAUTERINE GROWTH RETARDATION; KIDNEY MASS; LIVER WEIGHT; NONHUMAN; ORGANOGENESIS; RABBIT; RAT; TERATOGENICITY;

EID: 0037283749     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297082     Document Type: Article

References (18)

1. Coll, R., Moros, M., Xicota, M., In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates. Drugs Exp. Clin. Res. 8, 75 (1987)
2. Casal, M., Gutierrez, J., Ruiz, P., Preliminary study of the in vitro activity of irloxacin against mycobacteria. Chemotherapy 41, 204 (1995)
3. Loebstein, R., Addis, A., Ho, E., Pregnancy outcome following gestational exposure to fluoroquinolones: a multicenter prospective controlled study. Antimicrob. Agents Chemother. 42, 1336 (1998)
4. Guzmán, A., García, C., Demestre, I., Acute and sub-chronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents. Arzneim.-Forsch./Drug Res. 49 (I), 448 (1999)
5. Cukierski M. A., Hendrickx A. G., Prahalada S., Embryotoxicity studies of norfloxacin in cynomolgus monkeys. Teratology 46, 429 (1992)
6. Takayama S., Watanabe T., Akiyama Y., Reproductive toxicity of ofloxacin. Arzneim.-Forsch./Drug Res. 36 (II), 1244 (1986)
7. Ciprofloxacin Product Information Monograph. Marcel Dekker, New York (1988)
8. Stahlmann R., Lode H., Safety overview: toxicity, adverse effects and drug interactions. In: The Quinolones, V.T. Andriole (ed). Academic Press, London(1988)
9. Watanabe T., Fujikawa K., Harada S., Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits. Arzneim.-Forsch./Drug Res. 42 (I), 374 (1992)
10. Quinolones and pregnancy: worrying animal findings, few clinical data. Prescrire. Int. 8, 29 (1999)
11. Kim, J.-C., Yun, I.-H., Shin, H.-C., Embryo lethality and teratogenicity of a new fluoroquinolone antibacterial DW-116 in rats. Arch. Toxicol. 74, 120 (2000)
12. Wolfson, J. S., Hooper, D. C., Introduction to DNA gyrase, quinolones and quinolone resistance. In: Quinolones, P. B. Fernandes (ed.). Prous Science, Barcelona (1989)
13. Albertini S., Chetelat A. A., Genotoxicity of 17 gyrase-and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems. Mutagenesis 10, 343 (1995)
14. Christ, W., Lehnert, T., Ulbrich, B., Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10 (Suppl. 1), S141 (1988)
15. Patterson, D. R., Quinolone toxicity: methods of assessment. Am. J. Med. (Suppl. 6A), 91, 35S (1991)
16. Stahlmann, R., Lode, H., Toxicity of quinolones. Drugs 58 (Suppl. 2), 37 (1999)
17. Berkovitch, M., Pastuszak, A., Gazarian, M., Safety of the new quinolones in pregnancy. Obstet. Gynecol. 84, 535 (1994)
18. Schaefer, C., Amoura-Elefant, E., Vial T., Pregnancy out-come after prenatal quinolone exposure. Evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). Eur. J. Obstet. Gynecol. Reprod. Biol. 69, 83 (1996)